Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

7.9%

39 terminated/withdrawn out of 492 trials

Success Rate

84.5%

-2.0% vs industry average

Late-Stage Pipeline

6%

28 trials in Phase 3/4

Results Transparency

1%

2 of 212 completed trials have results

Key Signals

58 recruiting2 with results33 terminated6 withdrawn

Enrollment Performance

Analytics

N/A
218(73.4%)
Phase 2
38(12.8%)
Phase 3
21(7.1%)
Phase 1
12(4.0%)
Phase 4
7(2.4%)
Early Phase 1
1(0.3%)
297Total
N/A(218)
Phase 2(38)
Phase 3(21)
Phase 1(12)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (492)

Showing 20 of 492 trials
NCT07632521Not ApplicableNot Yet Recruiting

CLAP : Compare the Quality of 3D Modeling of the Wrist Based on the Cone Beam to the Gold Standard

Role: lead

NCT07036380Phase 2Recruiting

MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma

Role: lead

NCT01279096Phase 1Completed

Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia

Role: collaborator

NCT07492199Not Yet Recruiting

High Depth Exome Sequencing on DNA From a Salivary Sample by Mouth Smear.

Role: lead

NCT03671291Not ApplicableCompleted

Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV

Role: collaborator

NCT04767568Not ApplicableRecruiting

Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Screening

Role: lead

NCT05528952Phase 2Recruiting

Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Role: lead

NCT02565433Not ApplicableTerminated

Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)

Role: collaborator

NCT06796114Not ApplicableRecruiting

Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab

Role: lead

NCT06397846Not ApplicableRecruiting

Identification of Biomarkers Associated With the Presence of Malignant Pancreatic Lesions Compared to Benign Lesions.

Role: lead

NCT07469540Not ApplicableRecruiting

Effects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid Arthritis

Role: collaborator

NCT01648556Not ApplicableCompleted

Research of Predictive Factors to Immune Thrombopenic Purpura

Role: collaborator

NCT07467486Not Yet Recruiting

The EnvScore-Aorte Diagnostic Study Protocol for the Identification of Acute Aortic Syndrome

Role: lead

NCT02840058Not ApplicableCompleted

Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1

Role: lead

NCT07438015Not ApplicableNot Yet Recruiting

VEXUS-REA : Evaluation of Ultrasound Parameters of Venous Congestion in Patients in a Medical Intensive Care Unit

Role: lead

NCT07417709Not ApplicableNot Yet Recruiting

Interest of Adaptated Physical Activity (APA) on the K Recovery Constant, Reflecting the Rate of Muscle Oxygenation Recovery in Menopausal Women Suffering From Depression

Role: lead

NCT07411404Not ApplicableRecruiting

Assessment and Characterization of Sleep Among Video Game Adult Players Without Video Game Use Disorder : a Feasability Study

Role: lead

NCT06706349Not ApplicableRecruiting

Effect of Adapted Physical Activity on Sleep Quality in People With Alcohol Use Disorder

Role: lead

NCT07392788Not ApplicableNot Yet Recruiting

Early Gliflozin for Elderly Patients With Acute Decompensated Heart Failure in the Emergency Department

Role: lead

NCT07347210Phase 2Not Yet Recruiting

Evaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT Glioblastoma

Role: lead